Communicating with Your Oncology Team About Supplements Talking to your oncology team about supplements is key during cancer treatment
Dermal papilla cells, the master regulators at the base of each follicle, respond to AHK-Cu by increasing their numbers and extending their lifespan
Reach out to [email protected] Send page to friend via: Share via: You may also be interested in
Individuals with any of the following conditions should consult with their healthcare provider before use and may not be eligible for treatment: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Known hypersensitivity to GLP-1 or GLP-1/GIP medications or any formulation components, including additives such as vitamin B12 or cobalt Pregnancy or plans to become pregnant (therapy should be discontinued at least two months prior to planned pregnancy) Diabetic ketoacidosis (DKA) or type 1 diabetes Severe gastrointestinal disease (including gastroparesis or active inflammatory bowel disease) Severe cardiovascular disease (including unstable coronary artery disease or heart failure) Recent bariatric or gastrointestinal surgery within the past six months Active cancer currently undergoing chemotherapy or radiation treatment This list is not comprehensive
The purity of a research peptide isn't a luxury
Units, milligrams, milliliters, IU markings, they all blur together when you are staring at a tiny syringe trying to figure out how far to pull the plunger
